SEC Form D private-offering filing

Shuttle Pharmaceuticals Holdings, Inc.

Name: Shuttle Pharmaceuticals Holdings, Inc. - new SEC Form D private-offering filing, Gaithersburg, MD
Published: 2025-11-07

A new SEC Form D private-offering notice from Gaithersburg, MD, a $2,500,624 filer-stated offering target in Biotech. The source filing is one click away.

Shuttle Pharmaceuticals Holdings, Inc. site↗ Verified via SEC Form D

Clinical-stage pharmaceutical company developing radiation sensitizer drugs and other novel therapies to improve outcomes for cancer patients treated with radiation therapy.

Filed 2025-11-07Filed to raise $2,500,624First money in 2025-11-03Raised so far $2,499,998HQ (as filed) Gaithersburg, MDSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified shuttlepharma.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.